Skip to content
ppharmaranks
Menu

QBRELIS vs UNIVASC

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. QBRELIS and UNIVASC are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

70/100
70/100

Pharmacy pays

~$0.77 /30
~$29.42 /30

Type

RX
RX

Active ingredient

LISINOPRIL
MOEXIPRIL HYDROCHLORIDE

Manufacturer

Dosage forms

Solution
Tablet

Drug class

Angiotensin Converting Enzyme Inhibitor
Angiotensin Converting Enzyme Inhibitor

Boxed warning

Half-life

about 12 hours (the effective half-life, in adults with normal kidney function)

Treats

Diabetic Nephropathies, Heart Failure, Hypertension
Diabetic Nephropathies, Heart Failure, Hypertension

Get qbrelishigher-rated option

Advertising disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This never affects our independent ratings.

Get treatment online

Licensed online providers — consult & get prescribed if eligible.

Frequently asked questions

Which is better-rated, Qbrelis or Univasc?

Qbrelis and Univasc are tied at 3.5 out of 5 by our independent rating.

Which is cheaper, Qbrelis or Univasc?

Qbrelis costs pharmacies less to acquire — about $0.77 vs $29.42 for a 30-count supply, per the CMS NADAC survey. That gap is in the pharmacy's cost of goods, not necessarily in what you pay: your price is set afterwards by your insurer and the pharmacy.

What is the difference between Qbrelis and Univasc?

Qbrelis contains Lisinopril, while Univasc contains Moexipril Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.